- TWD20.44bn
- TWD16.43bn
- TWD2.69bn
- 89
- 41
- 61
- 74
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | PROSPECTUS | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 2,931 | 2,842 | 3,291 | 3,430 | 2,687 |
Cost of Revenue | |||||
Gross Profit | 1,479 | 1,337 | 1,636 | 1,741 | 1,491 |
Selling / General / Administrative Expenses | |||||
Research And Development | |||||
Total Operating Expenses | 1,961 | 1,988 | 2,199 | 2,276 | 1,781 |
Operating Profit | 969 | 854 | 1,092 | 1,154 | 906 |
Gain / Loss on Sale of Assets | |||||
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | 971 | 873 | 1,056 | 1,390 | 1,093 |
Provision for Income Taxes | |||||
Net Income After Taxes | 735 | 689 | 862 | 1,124 | 873 |
Net Income Before Extraordinary Items | |||||
Net Income | 735 | 689 | 862 | 1,124 | 873 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | 735 | 689 | 862 | 1,124 | 873 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 10.1 | 9.6 | 11.8 | 14.5 | 10.9 |
Dividends per Share |